Ceapro Management
Management criteria checks 3/4
Ceapro's CEO is Gilles Gagnon, appointed in Jan 2008, has a tenure of 16.25 years. total yearly compensation is CA$560.00K, comprised of 85.7% salary and 14.3% bonuses, including company stock and options. directly owns 1.9% of the company’s shares, worth CA$357.36K. The average tenure of the management team and the board of directors is 8.9 years and 9 years respectively.
Key information
Gilles Gagnon
Chief executive officer
CA$560.0k
Total compensation
| CEO salary percentage | 85.7% |
| CEO tenure | 16.3yrs |
| CEO ownership | 1.9% |
| Management average tenure | 8.9yrs |
| Board average tenure | 9yrs |
Recent management updates
Recent updates
The Returns At Ceapro (CVE:CZO) Aren't Growing
Aug 09
Returns At Ceapro (CVE:CZO) Are On The Way Up
Oct 15Ceapro's (CVE:CZO) Returns Have Hit A Wall
Jun 17Ceapro (CVE:CZO) Will Want To Turn Around Its Return Trends
Nov 19Be Wary Of Ceapro (CVE:CZO) And Its Returns On Capital
Jul 20Ceapro's (CVE:CZO) Robust Earnings Are Supported By Other Strong Factors
May 27Estimating The Fair Value Of Ceapro Inc. (CVE:CZO)
Apr 29Will Ceapro (CVE:CZO) Multiply In Value Going Forward?
Mar 01Is It Too Late To Consider Buying Ceapro Inc. (CVE:CZO)?
Feb 01Estimating The Fair Value Of Ceapro Inc. (CVE:CZO)
Jan 06
Ceapro Inc. (CVE:CZO) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Nov 28CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -CA$3m |
| Jun 30 2023 | n/a | n/a | -CA$759k |
| Mar 31 2023 | n/a | n/a | CA$2m |
| Dec 31 2022 | CA$560k | CA$480k | CA$4m |
| Sep 30 2022 | n/a | n/a | CA$6m |
| Jun 30 2022 | n/a | n/a | CA$6m |
| Mar 31 2022 | n/a | n/a | CA$5m |
| Dec 31 2021 | CA$560k | CA$480k | CA$3m |
| Sep 30 2021 | n/a | n/a | CA$2m |
| Jun 30 2021 | n/a | n/a | CA$844k |
| Mar 31 2021 | n/a | n/a | CA$1m |
| Dec 31 2020 | CA$507k | CA$480k | CA$2m |
| Sep 30 2020 | n/a | n/a | CA$3m |
| Jun 30 2020 | n/a | n/a | CA$2m |
| Mar 31 2020 | n/a | n/a | CA$630k |
| Dec 31 2019 | CA$518k | CA$480k | -CA$1m |
| Sep 30 2019 | n/a | n/a | -CA$855k |
| Jun 30 2019 | n/a | n/a | -CA$1m |
| Mar 31 2019 | n/a | n/a | -CA$657k |
| Dec 31 2018 | CA$555k | CA$480k | -CA$316k |
| Sep 30 2018 | n/a | n/a | -CA$2m |
| Jun 30 2018 | n/a | n/a | -CA$2m |
| Mar 31 2018 | n/a | n/a | -CA$1m |
| Dec 31 2017 | CA$1m | CA$480k | -CA$958k |
Compensation vs Market: Gilles's total compensation ($USD409.87K) is above average for companies of similar size in the Canadian market ($USD174.90K).
Compensation vs Earnings: Gilles's compensation has been consistent with company performance over the past year.
CEO
Gilles Gagnon (69 yo)
16.3yrs
Tenure
CA$560,000
Compensation
Mr. Gilles R. Gagnon, M.Sc. MBA, ICD D, serves as Independent Director of Aeterna Zentaris Inc. since January 1, 2020. He serves as the President of Spectrum Pharma Canada Inc. (Spectrum Canada).Mr. Gagno...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 16.3yrs | CA$560.00k | 1.9% CA$ 357.4k | |
| CFO & Corporate Secretary | 8.9yrs | CA$232.99k | 0.042% CA$ 7.8k | |
| Senior Director of Research & Technology | no data | no data | no data | |
| Senior Vice President of Technical Operations | less than a year | no data | no data |
8.9yrs
Average Tenure
Experienced Management: CZO's management team is seasoned and experienced (8.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 16.6yrs | CA$560.00k | 1.9% CA$ 357.4k | |
| Independent Director | 2yrs | CA$92.38k | no data | |
| Independent Director | 9.4yrs | CA$59.57k | 0.13% CA$ 24.4k | |
| Independent Chairman | 1.9yrs | CA$96.06k | no data | |
| Independent Director | 9yrs | CA$57.79k | 0.10% CA$ 18.8k |
9.0yrs
Average Tenure
Experienced Board: CZO's board of directors are considered experienced (9 years average tenure).